PolyVascular products

Congenital heart disease (CHD) is the most common birth defect and number one cause of infant mortality in the developed world. Twice as many children die from CHD than all childhood cancers combined. Our aim is to transform the care of children with congenital heart disease by developing an entirely new generation of valves.